US 11197844
Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer
granted A61KA61K31/155A61K31/337
Quick answer
US patent 11197844 (Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer) held by The Regents of the University of California expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/155, A61K31/337, A61K31/351, A61K31/366